{"title":"1例成人潜伏性自身免疫性糖尿病患者接种COVID-19疫苗后血糖控制急性恶化","authors":"Nicole J Altomare, David A. Cohen","doi":"10.33590/emjdiabet/21-00263","DOIUrl":null,"url":null,"abstract":"Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.","PeriodicalId":418035,"journal":{"name":"EMJ Diabetes","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Acute Worsening of Glycaemic Control in a Patient with Latent Autoimmune Diabetes of Adulthood After Receiving the COVID-19 Vaccine\",\"authors\":\"Nicole J Altomare, David A. Cohen\",\"doi\":\"10.33590/emjdiabet/21-00263\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.\",\"PeriodicalId\":418035,\"journal\":{\"name\":\"EMJ Diabetes\",\"volume\":\"39 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMJ Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33590/emjdiabet/21-00263\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjdiabet/21-00263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Acute Worsening of Glycaemic Control in a Patient with Latent Autoimmune Diabetes of Adulthood After Receiving the COVID-19 Vaccine
Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
